180 related articles for article (PubMed ID: 38684708)
1. Identifying therapeutic targets for cancer among 2074 circulating proteins and risk of nine cancers.
Smith-Byrne K; Hedman Å; Dimitriou M; Desai T; Sokolov AV; Schioth HB; Koprulu M; Pietzner M; Langenberg C; Atkins J; Penha RC; McKay J; Brennan P; Zhou S; Richards BJ; Yarmolinsky J; Martin RM; Borlido J; Mu XJ; Butterworth A; Shen X; Wilson J; Assimes TL; Hung RJ; Amos C; Purdue M; Rothman N; Chanock S; Travis RC; Johansson M; Mälarstig A
Nat Commun; 2024 Apr; 15(1):3621. PubMed ID: 38684708
[TBL] [Abstract][Full Text] [Related]
2. Proteome-wide mendelian randomization study implicates therapeutic targets in common cancers.
Ren F; Jin Q; Liu T; Ren X; Zhan Y
J Transl Med; 2023 Sep; 21(1):646. PubMed ID: 37735436
[TBL] [Abstract][Full Text] [Related]
3. Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis.
Yarmolinsky J; Díez-Obrero V; Richardson TG; Pigeyre M; Sjaarda J; Paré G; Walker VM; Vincent EE; Tan VY; Obón-Santacana M; Albanes D; Hampe J; Gsur A; Hampel H; Pai RK; Jenkins M; Gallinger S; Casey G; Zheng W; Amos CI; ; ; ; Smith GD; Martin RM; Moreno V
PLoS Med; 2022 Feb; 19(2):e1003897. PubMed ID: 35113855
[TBL] [Abstract][Full Text] [Related]
4. Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.
Zhang L; Xiong Y; Zhang J; Feng Y; Xu A
J Transl Med; 2024 Apr; 22(1):330. PubMed ID: 38576019
[TBL] [Abstract][Full Text] [Related]
5. Exploring the cross-cancer effect of circulating proteins and discovering potential intervention targets for 13 site-specific cancers.
Sun J; Luo J; Jiang F; Zhao J; Zhou S; Wang L; Zhang D; Ding Y; Li X
J Natl Cancer Inst; 2024 Apr; 116(4):565-573. PubMed ID: 38039160
[TBL] [Abstract][Full Text] [Related]
6. Genetically Raised Circulating Bilirubin Levels and Risk of Ten Cancers: A Mendelian Randomization Study.
Seyed Khoei N; Carreras-Torres R; Murphy N; Gunter MJ; Brennan P; Smith-Byrne K; Mariosa D; Mckay J; O'Mara TA; Jarrett R; Hjalgrim H; Smedby KE; Cozen W; Onel K; Diepstra A; Wagner KH; Freisling H
Cells; 2021 Feb; 10(2):. PubMed ID: 33671849
[TBL] [Abstract][Full Text] [Related]
7. Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses.
Murphy N; Carreras-Torres R; Song M; Chan AT; Martin RM; Papadimitriou N; Dimou N; Tsilidis KK; Banbury B; Bradbury KE; Besevic J; Rinaldi S; Riboli E; Cross AJ; Travis RC; Agnoli C; Albanes D; Berndt SI; Bézieau S; Bishop DT; Brenner H; Buchanan DD; Onland-Moret NC; Burnett-Hartman A; Campbell PT; Casey G; Castellví-Bel S; Chang-Claude J; Chirlaque MD; de la Chapelle A; English D; Figueiredo JC; Gallinger SJ; Giles GG; Gruber SB; Gsur A; Hampe J; Hampel H; Harrison TA; Hoffmeister M; Hsu L; Huang WY; Huyghe JR; Jenkins MA; Keku TO; Kühn T; Kweon SS; Le Marchand L; Li CI; Li L; Lindblom A; Martín V; Milne RL; Moreno V; Newcomb PA; Offit K; Ogino S; Ose J; Perduca V; Phipps AI; Platz EA; Potter JD; Qu C; Rennert G; Sakoda LC; Schafmayer C; Schoen RE; Slattery ML; Tangen CM; Ulrich CM; van Duijnhoven FJB; Van Guelpen B; Visvanathan K; Vodicka P; Vodickova L; Vymetalkova V; Wang H; White E; Wolk A; Woods MO; Wu AH; Zheng W; Peters U; Gunter MJ
Gastroenterology; 2020 Apr; 158(5):1300-1312.e20. PubMed ID: 31884074
[TBL] [Abstract][Full Text] [Related]
8. Identifying proteomic risk factors for overall, aggressive and early onset prostate cancer using Mendelian randomization and tumor spatial transcriptomics.
Desai TA; Hedman ÅK; Dimitriou M; Koprulu M; Figiel S; Yin W; Johansson M; Watts EL; Atkins JR; Sokolov AV; Schiöth HB; Gunter MJ; Tsilidis KK; Martin RM; Pietzner M; Langenberg C; Mills IG; Lamb AD; Mälarstig A; Key TJ; ; Travis RC; Smith-Byrne K
medRxiv; 2023 Sep; ():. PubMed ID: 37790472
[TBL] [Abstract][Full Text] [Related]
9. Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis.
Bouras E; Karhunen V; Gill D; Huang J; Haycock PC; Gunter MJ; Johansson M; Brennan P; Key T; Lewis SJ; Martin RM; Murphy N; Platz EA; Travis R; Yarmolinsky J; Zuber V; Martin P; Katsoulis M; Freisling H; Nøst TH; Schulze MB; Dossus L; Hung RJ; Amos CI; Ahola-Olli A; Palaniswamy S; Männikkö M; Auvinen J; Herzig KH; Keinänen-Kiukaanniemi S; Lehtimäki T; Salomaa V; Raitakari O; Salmi M; Jalkanen S; ; Jarvelin MR; Dehghan A; Tsilidis KK
BMC Med; 2022 Jan; 20(1):3. PubMed ID: 35012533
[TBL] [Abstract][Full Text] [Related]
10. Body size and composition and risk of site-specific cancers in the UK Biobank and large international consortia: A mendelian randomisation study.
Vithayathil M; Carter P; Kar S; Mason AM; Burgess S; Larsson SC
PLoS Med; 2021 Jul; 18(7):e1003706. PubMed ID: 34324486
[TBL] [Abstract][Full Text] [Related]
11. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.
Yarmolinsky J; Robinson JW; Mariosa D; Karhunen V; Huang J; Dimou N; Murphy N; Burrows K; Bouras E; Smith-Byrne K; Lewis SJ; Galesloot TE; Kiemeney LA; Vermeulen S; Martin P; Albanes D; Hou L; Newcomb PA; White E; Wolk A; Wu AH; Le Marchand L; Phipps AI; Buchanan DD; ; ; Zhao SS; Gill D; Chanock SJ; Purdue MP; Davey Smith G; Brennan P; Herzig KH; Järvelin MR; Amos CI; Hung RJ; Dehghan A; Johansson M; Gunter MJ; Tsilidis KK; Martin RM
EBioMedicine; 2024 Feb; 100():104991. PubMed ID: 38301482
[TBL] [Abstract][Full Text] [Related]
12. Circulating vitamin C concentration and risk of cancers: a Mendelian randomization study.
Fu Y; Xu F; Jiang L; Miao Z; Liang X; Yang J; Larsson SC; Zheng JS
BMC Med; 2021 Jul; 19(1):171. PubMed ID: 34325683
[TBL] [Abstract][Full Text] [Related]
13. Investigating the association between genetically proxied circulating levels of immune checkpoint proteins and cancer survival: protocol for a Mendelian randomisation analysis.
Bate T; Martin RM; Yarmolinsky J; Haycock PC
BMJ Open; 2024 Feb; 14(2):e075981. PubMed ID: 38365286
[TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
15. Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study.
Dimitrakopoulou VI; Tsilidis KK; Haycock PC; Dimou NL; Al-Dabhani K; Martin RM; Lewis SJ; Gunter MJ; Mondul A; Shui IM; Theodoratou E; Nimptsch K; Lindström S; Albanes D; Kühn T; Key TJ; Travis RC; Vimaleswaran KS; ; ; ; Kraft P; Pierce BL; Schildkraut JM
BMJ; 2017 Oct; 359():j4761. PubMed ID: 29089348
[No Abstract] [Full Text] [Related]
16. Insulin-like growth factor-1 and site-specific cancers: A Mendelian randomization study.
Larsson SC; Carter P; Vithayathil M; Kar S; Mason AM; Burgess S
Cancer Med; 2020 Sep; 9(18):6836-6842. PubMed ID: 32717139
[TBL] [Abstract][Full Text] [Related]
17. Modifiable pathways for colorectal cancer: a mendelian randomisation analysis.
Cornish AJ; Law PJ; Timofeeva M; Palin K; Farrington SM; Palles C; Jenkins MA; Casey G; Brenner H; Chang-Claude J; Hoffmeister M; Kirac I; Maughan T; Brezina S; Gsur A; Cheadle JP; Aaltonen LA; Tomlinson I; Dunlop MG; Houlston RS
Lancet Gastroenterol Hepatol; 2020 Jan; 5(1):55-62. PubMed ID: 31668584
[TBL] [Abstract][Full Text] [Related]
18. Novel Drug Targets for Ischemic Stroke Identified Through Mendelian Randomization Analysis of the Blood Proteome.
Chong M; Sjaarda J; Pigeyre M; Mohammadi-Shemirani P; Lali R; Shoamanesh A; Gerstein HC; Paré G
Circulation; 2019 Sep; 140(10):819-830. PubMed ID: 31208196
[TBL] [Abstract][Full Text] [Related]
19. Associations between circulating proteins and risk of breast cancer by intrinsic subtypes: a Mendelian randomisation analysis.
Shu X; Zhou Q; Sun X; Flesaker M; Guo X; Long J; Robson ME; Shu XO; Zheng W; Bernstein JL
Br J Cancer; 2022 Nov; 127(8):1507-1514. PubMed ID: 35882941
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisation.
Mälarstig A; Grassmann F; Dahl L; Dimitriou M; McLeod D; Gabrielson M; Smith-Byrne K; Thomas CE; Huang TH; Forsberg SKG; Eriksson P; Ulfstedt M; Johansson M; Sokolov AV; Schiöth HB; Hall P; Schwenk JM; Czene K; Hedman ÅK
Nat Commun; 2023 Nov; 14(1):7680. PubMed ID: 37996402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
